The Department for Business, Energy and Industrial Strategy (BEIS): Commitment Agreement

UK-London: Vaccines.

Section I: Contracting Authority

   I.1) Name, Addresses and Contact Point(s):
       The Department for Business, Energy and Industrial Strategy (BEIS)
       1 Victoria Street, London, SW1H 0ET, United Kingdom
       Tel. +44 02072155000, Email: VTFContracts@beis.gov.uk
       Main Address: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
       NUTS Code: UKI

   I.2) Joint procurement:
      The contract involves joint procurement: No          
      In the case of joint procurement involving different countries, state applicable national procurement law: Not Provided
      The contract is awarded by a central purchasing body: No

   I.4)Type of the contracting authority:
      Ministry or any other national or federal authority, including their regional or local subdivisions

   I.5) Main activity:
      General public services

Section II: Object Of The Contract

   II.1) Scope of the procurement

      II.1.1) Title: Commitment Agreement            
      Reference number: 3636/09/2020

      II.1.2) Main CPV code:
         33651600 - Vaccines.


      II.1.3) Type of contract: SUPPLIES

      II.1.4) Short description: The UK has joined the multilateral vaccine procurement initiative - COVAX. The UK has committed £71m to secure purchase rights for vaccine for up to 20% of the total UK population (~13.46M people) through the ‘self-financing’ arm of the facility (this is separate from the £548 contribution made to COVAX to support vaccine access for lower income countries).
COVAX provides an opportunity to secure access to additional vaccine candidates and further diversify the UK domestic portfolio.

      II.1.6) Information about lots
         This contract is divided into lots: No
            
      II.1.7) Total value of the procurement (excluding VAT)
          Value: 71,000,000
                  
         Currency:GBP            

   II.2) Description

      II.2.2) Additional CPV code(s):
      Not Provided

      II.2.3) Place of performance
      Nuts code:
      CH0 - SCHWEIZ/SUISSE/SVIZZERA
   
      Main site or place of performance:
      SCHWEIZ/SUISSE/SVIZZERA
             

      II.2.4) Description of the procurement: The UK joined COVAX through the ‘Optional Purchase Route’ which enables HMG to decide whether to purchase a specific vaccine candidate through COVAX once key information on terms become available. We have the chance to opt out of procurement before COVAX signs a binding Advance Purchase Agreement with a manufacturer (Decision Window 1) or at the point COVAX is due to confirm orders with a specific manufacturer (Decision Window 2). There is agreement in principle that COVAX will include an Exchange mechanism whereby participants can trade doses but this has not been set up so we do not have option to trade vaccines yet.

      II.2.5) Award criteria:
                  
      Price - Weighting: 100
            

      II.2.11) Information about options
         Options: No
         

      II.2.13) Information about European Union funds
         The procurement is related to a project and/or programme financed by European Union funds: No
         

      II.2.14) Additional information: Not Provided


Section IV: Procedure

IV.1) Description

   IV.1.1)Type of procedure: Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below (please complete Annex D1)


   IV.1.3) Information about a framework agreement or a dynamic purchasing system
      The procurement involves the establishment of a framework agreement: No       
      

   IV.1.6) Information about electronic auction
      An electronic auction has been used: No

   IV.1.8) Information about the Government Procurement Agreement (GPA)
      The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

   IV.2.1) Previous publication concerning this procedure
       Not Provided
   

   IV.2.9) Information about termination of call for competition in the form of a prior information notice
      The contracting authority will not award any further contracts based on the above prior information notice: No

Section V: Award of contract

Award Of Contract (No.1)

   Contract No: 3636/09/2020    
   Lot Number: Not Provided    
   Title: Commitment Agreement

   A contract/lot is awarded: Yes


   V.2) Award of contract

      V.2.1) Date of conclusion of the contract: 08/10/2020

      V.2.2) Information about tenders
         Number of tenders received: 1
         Number of tenders received from SMEs: Not Provided          
         Number of tenders received from tenderers from other EU Member States: Not Provided          
         Number of tenders received from tenderers from non-EU Member States: Not Provided          
         Number of tenders received by electronic means: Not Provided

      V.2.3) Name and address of the contractor

      The contract has been awarded to a group of economic operators: No
         
         Contractor (No.1)
             THE GAVI ALLIANCE, n/a
             Gavi Alliance, Chemin du Pommier 40, Le Grand-Saconnex, 1218, Switzerland
             NUTS Code: CH0
            The contractor is an SME: No

      V.2.4) Information on value of the contract/lot (excluding VAT)
         Initial estimated total value of the contract/lot: 71,000,000          
         Total value of the contract/lot: 71,000,000
         Currency: GBP

      V.2.5) Information about subcontracting
         The contract is likely to be subcontracted: No
         
Section VI: Complementary information

   VI.3) Additional information: To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=553855915

   VI.4) Procedures for review

      VI.4.1) Review body
          Department of Business, Energy & Industrial Strategy
          1 Victoria Street, Westminister,, London, SW1H 0ET, United Kingdom

      VI.4.3) Review procedure
         Precise information on deadline(s) for review procedures: Not Provided

      VI.4.4) Service from which information about the review procedure may be obtained
         Not Provided

   VI.5) Date of dispatch of this notice: 16/12/2020




ANNEX D

   1. Justification for the choice of the negotiated procedure without prior publication of a call for competition in accordance with Article 32 of Directive 2014/24/EU

      No tenders or no suitable tenders/requests to participate in response to: Not Provided

      The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive (for supplies only): No       
      
      The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons

      Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the directive: Yes

      Additional deliveries by the original supplier ordered under the strict conditions stated in the directive: No

      
      
      Procurement of supplies quoted and purchased on a commodity market: No

      Purchase of supplies or services on particularly advantageous terms: No


   3. Explanation
          COVAX services may be supplied only by Gavi and therefore competition is absent for technical reasons (Reg 32(2)(b)(ii)). Gavi may also be considered to have exclusive rights to provide the COVAX Facility by the nature of its operation (Reg 32(2)(b)(iii)).

The award of the contract to Gavi is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid 19 pandemic (Regulation 32(2)(c))